Elosulfase Alfa (Intravenous Route) Description and Brand Names - Mayo Clinic

Schedule your appointment now for safe in-person care.
Learn more: Mayo Clinic facts about coronavirus disease 2019 (COVID-19)
Latest on COVID-19 vaccination by site: Arizona patient vaccination updates , Florida patient vaccination updates , Rochester patient vaccination updates and Mayo Clinic Health System patient vaccination updates

Description and Brand Names

Drug information provided by: IBM Micromedex

US Brand Name

Vimizim

Descriptions

Elosulfase alfa injection is used to treat patients with mucopolysaccharidosis type A (Morquio A syndrome).

This medicine is to be given only by or under the direct supervision of your doctor.

This product is available in the following dosage forms:

Solution

Before Using

Portions of this document last updated: Feb. 01, 2021

Copyright © 2021 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.

Advertising & Sponsorship

Mayo Clinic Marketplace

Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.

Other Topics in Patient Care & Health Info

.

DRG-20095148